Skip to Main content Skip to Navigation
Journal articles

Probiotics from research to market: the possibilities, risks and challenges

Benoit Foligné 1 Catherine Daniel 1 Bruno Pot 1, *
* Corresponding author
1 Lactic Acid Bacteria & Mucosal Immunity - CIIL
CIIL - Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204
Abstract : Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scientific support. Today, probiotics are mainly used for gastrointestinal applications, their use can easily be extended to skin, oral and vaginal health. While most probiotics currently belong to food-grade species, the future may offer new functional microorganisms in food and pharma. This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community.
Document type :
Journal articles
Complete list of metadata
Contributor : Catherine Daniel Connect in order to contact the contributor
Submitted on : Tuesday, July 27, 2021 - 11:38:01 AM
Last modification on : Tuesday, October 19, 2021 - 11:56:33 PM




Benoit Foligné, Catherine Daniel, Bruno Pot. Probiotics from research to market: the possibilities, risks and challenges. Current Opinion in Microbiology, Elsevier, 2013, 16 (3), pp.284-292. ⟨10.1016/j.mib.2013.06.008⟩. ⟨hal-03300727⟩



Record views